Zenodo
What is the role of sodium-glucose co-transporter protein inhibitors in managing chronic kidney disease?
By Tripdatabase.
Abstract
Sodium-glucose co-transporter protein inhibitors significantly reduce CKD progression, kidney failure risk, and cardiovascular events, reinforcing their role in CKD management.
Keywords
- Chronic Kidney Disease and Diabetes
- sodium-glucose cotransporter inhibitors
- SGLT2 inhibitors
- chronic kidney disease
- chronic kidney disease progression
- kidney failure risk